Cost-effectiveness analysis: A tool in the hands of the clinician

被引：2
|
作者：
De Carlo, Marco [1 ]
机构：
[1] Azienda Osped Univ Pisana, Cardiothorac & Vasc Dept, Pisa, Italy
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2019年 / 26卷 / 08期
关键词：
RIVAROXABAN; ASPIRIN; DISEASE;
D O I：
10.1177/2047487318822357
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：855 / 857
页数：3
相关论文
共 50 条
  • [1] Markov Influence Diagrams: A Graphical Tool for Cost-effectiveness Analysis
    Diez, Francisco J.
    Yebra, Mar
    Bermejo, Inigo
    Palacios-Alonso, Miguel A.
    Arias Calleja, Manuel
    Luque, Manuel
    Perez-Martin, Jorge
    MEDICAL DECISION MAKING, 2017, 37 (02) : 183 - 195
  • [2] Cost, Effectiveness, and Cost-Effectiveness
    Diamond, George A.
    Kaul, Sanjay
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (01): : 49 - 54
  • [3] Cost-effectiveness analysis of pneumococcal vaccination in Spain
    Morano, Raul
    Perez, Fernan
    Brosa, Max
    Perez Escolano, Isabel
    GACETA SANITARIA, 2011, 25 (04) : 267 - 273
  • [4] Costing and Perspective in Published Cost-Effectiveness Analysis
    Neumann, Peter J.
    MEDICAL CARE, 2009, 47 (07) : S28 - S32
  • [5] QALYs in cost-effectiveness analysis: an overview for cardiologists
    Wouters, Olivier J.
    Naci, Huseyin
    Samani, Nilesh J.
    HEART, 2015, 101 (23) : 1868 - 1873
  • [6] Cost-effectiveness analysis of rotavirus vaccination in Argentina
    Uruena, Analia
    Pippo, Tomas
    Betelu, Maria Sol
    Virgilio, Federico
    Hernandez, Laura
    Giglio, Norberto
    Gentile, Angela
    Diosque, Maximo
    Vizzotti, Carla
    VACCINE, 2015, 33 : A126 - A134
  • [7] Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States A Cost-Effectiveness Analysis
    Neilan, Anne M.
    Landovitz, Raphael J.
    Le, Mylinh H.
    Grinsztejn, Beatriz
    Freedberg, Kenneth A.
    McCauley, Marybeth
    Wattananimitgul, Nattanicha
    Cohen, Myron S.
    Ciaranello, Andrea L.
    Clement, Meredith E.
    Reddy, Krishna P.
    Hyle, Emily P.
    Paltiel, A. David
    Walensky, Rochelle P.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (04) : 479 - +
  • [8] Understanding and Anticipating Lag-Time Bias in Cost-Effectiveness Studies: The Role of Time in Cost-Effectiveness Analysis
    van de Wetering, Gijs
    Rikkert, Marcel Olde
    van der Wilt, Gert Jan
    Adang, Eddy
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2014, 30 (06) : 608 - 611
  • [9] Cost-Effectiveness Analysis of Rivaroxaban in Chinese Patients With Stable Cardiovascular Disease
    Feng, Tianyu
    Zheng, Zhou
    Gao, Shang
    Xu, Jiaying
    Cao, Pen
    Jia, Huanhuan
    Yu, Xihe
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] Appropriate Cohorts for Cost-Effectiveness Analysis: To Mix or Not to Mix?
    Kuntz, Karen M.
    Fenwick, Elisabeth
    Briggs, Andrew
    MEDICAL DECISION MAKING, 2010, 30 (04) : 424 - 425
12345